MDAI Spectral AI, Inc. Class A Common Stock

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

MDAI — —

What changed

Recent filings, trades and moves
Key stats
About
Industry (SIC)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
65
List Date
2023-09-12
CIK
0001833498
Next Earnings
2026-11-10 (After-Close)
EPS Forecast
($0.14)
Headquarters
Dallas, TX
Homepage
https://www.spectral-ai.com

Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'23'24'25'26Avg
Jan---17.39%-29.30%20.69%-8.67%
Feb---8.68%-4.40%-17.65%-10.24%
Mar--5.97%-27.67%4.26%-5.81%
Apr---23.61%8.33%42.36%9.03%
May---3.49%24.03%-3.72%5.61%
Jun--10.00%52.15%-14.78%15.79%
Jul---14.36%-8.15%-12.68%-11.73%
Aug---12.80%-18.22%-2.48%-11.17%
Sep-50.55%-27.40%19.37%7.10%-12.87%
Oct1.83%38.46%-6.99%-7.83%6.37%
Nov-6.27%30.61%-18.69%-0.33%*1.33%
Dec-26.57%28.64%-5.96%---1.30%
Total-65.34%-18.23%-36.27%1.41%-29.61%
* Only 4 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.51
SMA 50: $1.57
SMA 200: $1.70
Current: $1.51
EMA 12: $1.51
EMA 26: $1.53
MACD: -0.0276 | Signal: -0.0008
BEARISH
ADX (14): 16.43
RANGE
+DI: 15.27
−DI: 23.11

Momentum Oscillators

RSI (14): 48.05
NEUTRAL
Stoch %K: 34.67
Stoch %D: 32.50
Williams %R: -44.00

Volume & Volatility

BB Upper: $1.59
BB Lower: $1.43
NEUTRAL
OBV: 48,410,580
Vol SMA 20: 134,318
Vol ROC: 99.37%
ATR: $0.08
True Range: $0.10
HV 20: 56.0%
HV 30: 49.5%
HV 60: 40.5%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Written before MDAI’s Aug 11 earnings report, so it doesn’t reflect the results.

Here is my comprehensive stock analysis report for MDAI:

Executive Summary

Overall Assessment: NEUTRAL (confidence level 6/10)

Key Drivers:

  • Bullish momentum signals from MACD
  • Neutral RSI reading
  • Positive news sentiment from recent headlines

Primary Risks:

  • High volatility, potentially leading to large price swings
  • Lack of earnings data, making it difficult to assess the company's financial performance

Investment Thesis:

MDAI appears to be in a neutral zone, with both bullish and bearish signals present. The stock is experiencing high volatility, which may make it challenging to pinpoint a clear direction. However, the positive news sentiment from recent headlines suggests that there are underlying drivers that could propel the stock higher.

Recent News Sentiment Impact:

The recent news headlines have had a neutral impact on my assessment of MDAI's potential. The company has been featured in various conferences and has received positive coverage for its DeepView System. However, the lack of earnings data and high volatility make it difficult to fully assess the company's financial performance.

Technical Analysis

Trend Direction:

  • Short-term: Neutral
  • Medium-term: Uptrend
  • Long-term: Downtrend

Support/Resistance Levels:

  • Upper Bollinger Band: $2.63
  • Middle Bollinger Band: $2.28
  • Lower Bollinger Band: $1.93

Momentum Signals:

  • MACD signal line crossover above the zero line, indicating bullish momentum
  • RSI reading of 45.65 indicates a neutral trend
  • Williams %R reading of -79.13 suggests that the stock is oversold

Volume Analysis:

  • Volume SMA 20: 1151154.35
  • On-Balance Volume (OBV): 51351892.28
  • Volume Rate of Change: -11.55%

News & Sentiment Analysis

Recent Headlines Summary:

The recent news headlines have been mostly neutral, with some positive coverage for the company's DeepView System.

Sentiment Assessment:

Aggregated sentiment is NEUTRAL, reflecting the mixed nature of the recent headlines.

Catalyst Identification:

  • Upcoming earnings release (no date specified)
  • Potential product launches or regulatory approvals

Market Narrative:

The news sentiment aligns with the neutral trend direction and high volatility. The lack of earnings data makes it difficult to assess the company's financial performance, but the positive coverage for the DeepView System suggests that there may be underlying drivers that could propel the stock higher.

Risk & Volatility Assessment

Risk Interpretation:

  • Beta: 1.41 (vs SPY), indicating high risk relative to the market

Volatility Regime:

  • Current volatility is high, with a True Range of $0.19 and an Average True Range (ATR) of $0.22

Options Market Signals:

  • No options data available

Downside Protection:

  • Support levels: Lower Bollinger Band ($1.93), RSI oversold level (30)

Market Context & Positioning

Sector Performance:

  • MDAI is performing relatively well within its sector, with a positive correlation to the broader market

Institutional Activity:

  • No recent institutional activity data available

Correlation Analysis:

  • Correlation coefficient: 0.22, indicating a low degree of correlation between MDAI and the broader market

Relative Valuation:

  • Position within trading range: Neutral

Key Levels & Action Items

Critical Price Levels:

  • Support: Lower Bollinger Band ($1.93), RSI oversold level (30)
  • Resistance: Upper Bollinger Band ($2.63)

Breakout/Breakdown Levels:

  • No specific levels identified, but the stock's high volatility suggests that there may be opportunities for large price movements

Time-Sensitive Catalysts:

  • Upcoming earnings release (no date specified)
  • Potential product launches or regulatory approvals

Risk Management:

  • Stop-loss levels: Lower Bollinger Band ($1.93), RSI oversold level (30)
  • Position sizing considerations: Based on the stock's high volatility, it may be prudent to maintain a smaller position size.

I hope this comprehensive analysis meets your requirements!

Generated

MDAI Options Activity & IV Rank

Loading options activity...
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 1.3119
Alpha: -21.17%
Correlation: 0.2815
R-Squared: 7.9%
Stock Volatility: 64.2%
Market Volatility: 13.8%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own MDAI
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Rockefeller Capital Management Family office
Rockefeller family
$0K
0.00%
#4635 of 4729new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

MDAI Institutional Ownership (13F)

Filings for 2026-06-30 · 8 already for 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

32 filers4,665,540 shares$8.04M value
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 994,410 $1.72M 21.41% — 2026-06-30
2 Highlander Partners, L.P. 900,000 $1.56M 19.38% — 2026-06-30
3 Marshall Wace, LLP Custodian 827,454 $1.43M 17.81% — 2026-06-30
4 BRIDGEWAY CAPITAL MANAGEMENT, LLC 287,000 $496.51K 6.18% — 2026-06-30
5 Jane Street Group, LLC Custodian 226,319 $391.53K 4.87% — 2026-06-30
6 UBS Group AG Custodian 225,823 $390.67K 4.86% — 2026-06-30
7 Geode Capital Management, LLC Custodian 230,400 $382.53K 4.76% — 2026-09-30
8 BlackRock, Inc. Custodian 161,777 $279.87K 3.48% — 2026-06-30
9 LPL Financial LLC Custodian 163,801 $271.91K 3.38% — 2026-09-30
10 Vanguard Fiduciary Trust Co 142,664 $246.81K 3.07% — 2026-06-30
11 Rathbones Group PLC 87,045 $150.59K 1.87% — 2026-06-30
12 State Street Corp 75,600 $130.79K 1.63% — 2026-06-30
13 Forum Financial Management, LP 60,501 $100.43K 1.25% — 2026-09-30
14 Northern Trust Corp Custodian 50,547 $87.45K 1.09% — 2026-06-30
15 Virtu Financial LLC 40,979 $71.00K 0.88% — 2026-06-30
16 XTX Topco Ltd 32,927 $56.96K 0.71% — 2026-06-30
17 N.E.W. Advisory Services LLC 20,010 $34.62K 0.43% — 2026-06-30
18 JPMorgan Chase & Co Custodian 20,259 $34.24K 0.43% — 2026-06-30
19 Royal Bank of Canada Custodian 15,452 $27.00K 0.34% — 2026-06-30
20 Morgan Stanley Custodian 13,799 $23.87K 0.30% — 2026-06-30
21 Raymond James Financial, Inc. Custodian 12,800 $22.14K 0.28% — 2026-06-30
22 Tower Research Capital LLC (TRC) Custodian 12,121 $20.97K 0.26% — 2026-06-30
23 Philip James Wealth Mangement, LLC 12,000 $19.92K 0.25% — 2026-09-30
24 Engineers Gate Manager LP 11,046 $19.11K 0.24% — 2026-06-30
25 StoneX Group Inc. 11,034 $18.13K 0.23% — 2026-09-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

MDAI Insider Trading (Form 4)

Latest: 2026-09-29
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-29 John Michael DiMaio Director Award (A) +32,000 $1.62 $51.8K EDGAR
2026-09-25 John Michael DiMaio Director Award (A) +60,000 $1.67 $100.2K EDGAR
2026-09-21 John Michael DiMaio Director Award (A) +32,000 $1.66 $53.2K EDGAR
2026-09-14 John Michael DiMaio Director Award (A) +32,000 $1.58 $50.6K EDGAR
2026-08-17 John Michael DiMaio Director Award (A) +35,000 $1.64 $57.4K EDGAR
2026-06-29 John Michael DiMaio Director Award (A) +44,000 $1.72 $75.7K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

MDAI Insider Holdings

1 insider · @ $1.51
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 John Michael DiMaio Director 2,922,847 $4.43M $0 6 2026-09-29
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

MDAI Board & Officers

As of SEC filings through Sep 29, 2026

Directors 5

Officers 1

Changes in the last 10 years (50)
May 20, 2026Deepak Sadagopan first on file as a director
Apr 27, 2026Marion Ann Snyder first on file as a director
Apr 6, 2026Vincent S. Capone listed as Chief Executive Officer (previously CFO and General Counsel) in SEC filings
Jun 10, 2025John Michael DiMaio no longer listed as a 10% owner in SEC filings
Oct 14, 2024The company announced the departure of Peter M Carlson from the board in an SEC filing
Oct 14, 2024The company announced the departure of Peter M Carlson as Chief Executive Officer in an SEC filing
May 14, 2024Stan Micek first on file as Chief Operating Officer
May 14, 2024John Michael DiMaio first listed as a director in an SEC filing
May 13, 2024Vincent S. Capone listed as CFO and General Counsel (previously General Counsel) in SEC filings
May 13, 2024Peter M Carlson first on file as a director
May 13, 2024Peter M Carlson first on file as Chief Executive Officer
May 13, 2024Jeremiah A. Sparks first on file as Chief Commerical Officer
May 13, 2024Erich Spangenberg first listed as a director in an SEC filing
Mar 29, 2024The company announced the departure of Nikolaos Pagoulatos as Chief Operating Officer in an SEC filing
Feb 29, 2024The company announced the departure of Wensheng Fan from the board in an SEC filing
Feb 29, 2024The company announced the departure of Wensheng Fan as Chief Executive Officer in an SEC filing
Jan 30, 2024The company announced the departure of Michael Patrick Murphy from the board in an SEC filing
Sep 13, 2023Michael Patrick Murphy first listed as a director in an SEC filing
Sep 13, 2023Heather Bellini reported in an SEC filing no longer being a director
Sep 13, 2023Franklin S. Edmonds Jr. reported in an SEC filing no longer being a director
Not reported recently (13)
  • Erich Spangenberg · Last reported as a 10% owner in an SEC filing dated May 17, 2024
  • Stan Micek · Last reported as Chief Operating Officer in an SEC filing dated May 14, 2024
  • Jeremiah A. Sparks · Last reported as Chief Commerical Officer in an SEC filing dated May 13, 2024
  • ELS 1960 Family, L.P. · Last reported as a 10% owner in an SEC filing dated Sep 26, 2023
  • Jeffrey Edward Thatcher · Last reported as Chief Scientist in an SEC filing dated Sep 14, 2023
  • Rosecliff Acquisition Sponsor I LLC · Last reported as a director in an SEC filing dated Sep 13, 2023
  • Nils Windler · Last reported as Chief Financial Officer in an SEC filing dated Sep 13, 2023
  • Xiaojia Cynthia Cai · Last reported as a director in an SEC filing dated Sep 13, 2023
  • Goldman Sachs & Co. LLC · Last reported as a 10% owner in an SEC filing dated Feb 10, 2023
  • Goldman Sachs Group Inc · Last reported as a 10% owner in an SEC filing dated Feb 10, 2023
  • Michael Patrick Murphy · Last reported as a 10% owner in an SEC filing dated Feb 11, 2021
  • Jordan Zimmerman · Last reported as a director in an SEC filing dated Feb 11, 2021
  • Kieran Goodwin · Last reported as a director in an SEC filing dated Feb 11, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

MDAI Proposed Insider Sales (Form 144)

Latest: 2025-07-21
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2025-07-21 Erich Spangenberg; ELS 1960 Family, L.P. Former Director 736,131 $1.85M 2025-07-21 B. Riley Wealth Management, Inc. — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-09-15
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-09-15 Regulation FD disclosure EDGAR
2026-08-12 Earnings results · Regulation FD disclosure EDGAR
2026-07-08 Director or officer change · Regulation FD disclosure EDGAR
2026-06-01 Shareholder vote results · Regulation FD disclosure EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-08-11 0001213900-26-087764 EDGAR
ETF Holders
3 ETFs hold MDAI
3 shown · $1.75M total exposure · 0.01% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $1.2M — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $410,857 — 2026-09-30
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.01% $124,412 $1.2B 2026-11-06
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

MDAI vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
SYK Stryker Corporation $124.1B 34.7 +7.9% −6.4% 26
MMM 3M Company $95.5B 28.4 +1.7% +17.6% 23
BSX Boston Scientific Corp. $62.0B 18.8 +8.9% −53.2% 20
BDX Becton, Dickinson and Co. $57.7B 54.8 +6.4% +11.1% 28
MDLN Medline Inc. Class A common stock $34.8B 0.0 — +1.5% 4
RMD ResMed Inc. $33.1B 21.6 +9.0% −3.3% 22
DXCM DexCom, Inc. $29.6B 31.9 +13.0% +21.8% 41
WST West Pharmaceutical Services, Inc. $27.9B 46.2 +12.6% +49.0% 17
MDAI Spectral AI, Inc. Class A Common Stock $48M — — +4.5% —
Peer median $46.3B 30.1 +8.9% +6.3% 23

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.